Cargando…

A Wake-Up Call: We Need Phage Therapy Now

The rise of multidrug-resistant bacteria has resulted in an increased interest in phage therapy, which historically preceded antibiotic treatment against bacterial infections. To date, there have been no reports of serious adverse events caused by phages. They have been successfully used to cure hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Moelling, Karin, Broecker, Felix, Willy, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316858/
https://www.ncbi.nlm.nih.gov/pubmed/30563034
http://dx.doi.org/10.3390/v10120688
_version_ 1783384629213921280
author Moelling, Karin
Broecker, Felix
Willy, Christian
author_facet Moelling, Karin
Broecker, Felix
Willy, Christian
author_sort Moelling, Karin
collection PubMed
description The rise of multidrug-resistant bacteria has resulted in an increased interest in phage therapy, which historically preceded antibiotic treatment against bacterial infections. To date, there have been no reports of serious adverse events caused by phages. They have been successfully used to cure human diseases in Eastern Europe for many decades. More recently, clinical trials and case reports for a variety of indications have shown promising results. However, major hurdles to the introduction of phage therapy in the Western world are the regulatory and legal frameworks. Present regulations may take a decade or longer to be fulfilled. It is of urgent need to speed up the availability of phage therapy.
format Online
Article
Text
id pubmed-6316858
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63168582019-01-10 A Wake-Up Call: We Need Phage Therapy Now Moelling, Karin Broecker, Felix Willy, Christian Viruses Review The rise of multidrug-resistant bacteria has resulted in an increased interest in phage therapy, which historically preceded antibiotic treatment against bacterial infections. To date, there have been no reports of serious adverse events caused by phages. They have been successfully used to cure human diseases in Eastern Europe for many decades. More recently, clinical trials and case reports for a variety of indications have shown promising results. However, major hurdles to the introduction of phage therapy in the Western world are the regulatory and legal frameworks. Present regulations may take a decade or longer to be fulfilled. It is of urgent need to speed up the availability of phage therapy. MDPI 2018-12-05 /pmc/articles/PMC6316858/ /pubmed/30563034 http://dx.doi.org/10.3390/v10120688 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Moelling, Karin
Broecker, Felix
Willy, Christian
A Wake-Up Call: We Need Phage Therapy Now
title A Wake-Up Call: We Need Phage Therapy Now
title_full A Wake-Up Call: We Need Phage Therapy Now
title_fullStr A Wake-Up Call: We Need Phage Therapy Now
title_full_unstemmed A Wake-Up Call: We Need Phage Therapy Now
title_short A Wake-Up Call: We Need Phage Therapy Now
title_sort wake-up call: we need phage therapy now
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316858/
https://www.ncbi.nlm.nih.gov/pubmed/30563034
http://dx.doi.org/10.3390/v10120688
work_keys_str_mv AT moellingkarin awakeupcallweneedphagetherapynow
AT broeckerfelix awakeupcallweneedphagetherapynow
AT willychristian awakeupcallweneedphagetherapynow
AT moellingkarin wakeupcallweneedphagetherapynow
AT broeckerfelix wakeupcallweneedphagetherapynow
AT willychristian wakeupcallweneedphagetherapynow